Núria Montserrat rep el premi Íñigo Álvarez de Toledo
Núria Montserrat, ICREA research professor and principal investigator of the “Pluripotency for organ regeneration” group at IBEC, has unanimously won the XXXI Íñigo Álvarez de Toledo Award for Basic Research granted by the “Fundaciópn Renal Íñigo Álvarez de Toledo”.
Núria Montserrat, ICREA research professor and principal investigator of the “Pluripotency for organ regeneration” group at IBEC, has unanimously won the XXXI Íñigo Álvarez de Toledo Award for Basic Research granted by the “Fundaciópn Renal Íñigo Álvarez de Toledo”. Sa Majestat la Reina Sofia va fer entrega dels premis d’investigació en nefrologia als guanyadors de les dues últimes edicions, corresponents a les convocatòries de 2018 i 2019.
Experts at Institute for Bioengineering of Catalonia (IBEC) led by Josep Samitier, the Director of the Institute, have contributed to an international project supported by the European Union to study red blood cells under realistic physiological conditions. 
BioVac, a project led jointly by the Institute for Bioengineering of Catalonia (IBEC) and the Catalan Institute of Nanoscience and Nanotechnology (ICN2) has been awarded the BIST Ignite Awards 2020.
The institute for Bioengineering of Catalonia (IBEC) and the Institute for Complex Molecular Systems (ICMS), a research institute of the Eindhoven University of Technology (TU/e), have signed the first agreement between the two institutes to foster their collaboration. Both research centres share similarities such as their multidisciplinarity, their active missions to connect with industry and clinicians, and a strong research in nanomedicine, chemical biology, chip technology, regenerative medicine and tissue engineering. This institutional alliance will allow to share resources, knowledge and provide mobility programs. 
A group of researchers from the Institute for Bioengineering of Catalonia (IBEC) leads the European project BLOC, an initiative led by researchers Javier Ramón and Irene Marco that seeks to evaluate the response to different drugs in metabolic diseases using organ-in-a- chip by using nuclear magnetic resonance (NMR). For this, the consortium will have a budget of almost 3 million euros, financed by the Horizon 2020 FET Open program.